XM does not provide services to residents of the United States of America.
B
B

BristolMyer

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Bristol Myers Squibb Announces Dividend Increase

BRIEF-Bristol Myers Squibb Announces Dividend Increase Dec 11 (Reuters) - Bristol-Myers Squibb Co BMY.N : BRISTOL MYERS SQUIBB ANNOUNCES DIVIDEND INCREASE BRISTOL-MYERS SQUIBB CO - BRISTOL MYERS SQUIBB DECLARES QUARTERLY DIVIDEND OF $0.62 PER SHARE Source text: nBw8hjj4Ba Further company coverage: BMY.N
B

Health Rounds: New combination treatments promising for blood cancers

Health Rounds: New combination treatments promising for blood cancers Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here . By Nancy Lapid Dec 10 (Reuters) - Hello Health Rounds Readers! Today we cover a trio of studies on combination therapies presented at one of the year's most important meetings on blood disorders and cancers, the American Society of Hematology meeting in San D
A
B
R

U.S. Jll, Mongodb, Rigel Pharmaceuticals

U.S. RESEARCH ROUNDUP-Jll, Mongodb, Rigel Pharmaceuticals Dec 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Jll, Mongodb and Rigel Pharmaceuticals, on Tuesday. HIGHLIGHTS * Jll JLL.N : KBW raises target price to $325 from $292 * Mongodb Inc MDB.O : Barclays raises target price to $400 from $375 * Rigel Pharmaceuticals Inc RIGL.O : B.
A
A
B
C
E
M
M
M
O
T
A
B
G
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.